Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 13.968.0318.19-3.744.71

What is the latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 13.96 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202413.96
Mar20238.03
Mar202218.19
Mar2021-3.74
Mar20204.71

How is Core EBITDA Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 13.96
73.85
Mar2023 8.03
-55.85
Mar2022 18.19
Positive
Mar2021 -3.74
Negative
Mar2020 4.71 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹38,471.6 Cr -0.6% -4.8% 27.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-0.6%

-4.8%

27.7%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses